Trenchant Technologies Capital Corp. is an investment issuer company. The Company is focused primarily on seeking investment in companies introducing novel technologies, including Artificial Intelligence and Quantum Computing, to traditional businesses primarily in the medical, biomedical, and technologies sectors. It has entered into an agreement to acquire Limitless Quantum Computing Solutions Inc. Limitless Quantum is engaged in developing a quantum-resistant blockchain security platform. The Company has also acquired a 20% ownership interest in GNQ Insilico from the parent company, My Next Health Inc. GNQ Insilico is a health tech company. GNQ Insilico's technology platform can accelerate research processes, enhance genomic insights, and contribute to advancements in precision medicine and healthcare.